Drug recall · July 18, 2012
Trizivir recall
Why: Adulterated Presence of Foreign Tablets: Trizivir 300/150/300 mg tables, Lot 0ZP5128 may incorrectly contain Lexiva 700 mg tablets.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Trizivir (abacavir sulfate 300mg, lamivudine 150 mg and zidovudine 300 mg), 60 Tablets, Rx only, Manufactured for: ViiV Healthcare, Research Triangle Park, NC 27709 by: GlaxoSmithKline, Research Triangle Park, NC 27709, NDC 49702-217-18
- Lots / codes
Lot #0ZP5128 exp; 8/2013
- Quantity
- 14,465 bottles
- Company
- GlaxoSmithKline Inc, Zebulon, NC
- Distribution
- Nationwide
- Initiated
- June 4, 2012 · Voluntary: Firm initiated
- Classified
- July 12, 2012
- Reported
- July 18, 2012
- Ended
- September 4, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lamivudine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.